» Articles » PMID: 28750018

Pancreatic Cancer Cell/fibroblast Co-culture Induces M2 Like Macrophages That Influence Therapeutic Response in a 3D Model

Overview
Journal PLoS One
Date 2017 Jul 28
PMID 28750018
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer (PC) remains one of the most challenging solid tumors to treat with a high unmet medical need as patients poorly respond to standard-of-care-therapies. Prominent desmoplastic reaction involving cancer-associated fibroblasts (CAFs) and the immune cells in the tumor microenvironment (TME) and their cross-talk play a significant role in tumor immune escape and progression. To identify the key cellular mechanisms induce an immunosuppressive tumor microenvironment, we established 3D co-culture model with pancreatic cancer cells, CAFs and monocytes. Using this model, we analyzed the influence of tumor cells and fibroblasts on monocytes and their immune suppressive phenotype. Phenotypic characterization of the monocytes after 3D co-culture with tumor/fibroblast spheroids was performed by analyzing the expression of defined cell surface markers and soluble factors. Functionality of these monocytes and their ability to influence T cell phenotype and proliferation was investigated. 3D co-culture of monocytes with pancreatic cancer cells and fibroblasts induced the production of immunosuppressive cytokines which are known to promote polarization of M2 like macrophages and myeloid derived suppressive cells (MDSCs). These co-culture spheroid polarized monocyte derived macrophages (MDMs) were poorly differentiated and had an M2 phenotype. The immunosuppressive function of these co-culture spheroids polarized MDMs was demonstrated by their ability to inhibit CD4+ and CD8+ T cell activation and proliferation in vitro, which we could partially reverse by 3D co-culture spheroid treatment with therapeutic molecules that are able to re-activated spheroid polarized MDMs or block immune suppressive factors such as Arginase-I.

Citing Articles

Osteosarcoma tumor microenvironment: the key for the successful development of biologically relevant 3D in vitro models.

Rodrigues J, Sarmento B, Leite Pereira C In Vitro Model. 2025; 1(1):5-27.

PMID: 39872973 PMC: 11756501. DOI: 10.1007/s44164-022-00008-x.


Pharmacological Vitamin C-induced high HO generation mediates apoptotic cell death by caspase 3/7 activation in breast cancer tumor spheroids.

Mussa A, Hamid M, Hajissa K, Murtadha A, Al-Hatamleh M, Mokhtar N J Transl Med. 2025; 23(1):31.

PMID: 39780231 PMC: 11707935. DOI: 10.1186/s12967-024-06016-7.


TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness.

di Miceli N, Baioni C, Barbieri L, Danielli D, Sala E, Salvioni L Cancers (Basel). 2024; 16(21).

PMID: 39518142 PMC: 11545076. DOI: 10.3390/cancers16213705.


Cold and hot tumors: from molecular mechanisms to targeted therapy.

Wu B, Zhang B, Li B, Wu H, Jiang M Signal Transduct Target Ther. 2024; 9(1):274.

PMID: 39420203 PMC: 11491057. DOI: 10.1038/s41392-024-01979-x.


Combined PET Radiotracer Approach Reveals Insights into Stromal Cell-Induced Metabolic Changes in Pancreatic Cancer In Vitro and In Vivo.

Doctor A, Laube M, Meister S, Kiss O, Kopka K, Hauser S Cancers (Basel). 2024; 16(19).

PMID: 39410013 PMC: 11475921. DOI: 10.3390/cancers16193393.


References
1.
Joyce J, Pollard J . Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009; 9(4):239-52. PMC: 3251309. DOI: 10.1038/nrc2618. View

2.
Delitto D, Black B, Sorenson H, Knowlton A, Thomas R, Sarosi G . The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival. BMC Cancer. 2015; 15:783. PMC: 4619553. DOI: 10.1186/s12885-015-1820-x. View

3.
Berd D, MAGUIRE Jr H, Mastrangelo M, Murphy G . Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine. Cancer Immunol Immunother. 1994; 39(3):141-7. PMC: 11038623. DOI: 10.1007/BF01533378. View

4.
Winograd R, Byrne K, Evans R, Odorizzi P, Meyer A, Bajor D . Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. Cancer Immunol Res. 2015; 3(4):399-411. PMC: 4390506. DOI: 10.1158/2326-6066.CIR-14-0215. View

5.
Nyga A, Cheema U, Loizidou M . 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal. 2011; 5(3):239-48. PMC: 3145874. DOI: 10.1007/s12079-011-0132-4. View